Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 -- Adlai Nortye Ltd. , a clinical-stage biotechnology company focused on the development of innovative cancer therapies,...

Related Keywords

New York ,United States ,New Jersey ,Memorial Sloan Kettering Cancer Center ,Singapore ,China ,Canada ,Hangzhou ,Zhejiang ,Amanda Kong ,Adlai Nortye ,Charles Zhou ,Carsten Lu ,Exchange Commission ,Head Of Research ,Nasdaq ,Novartis ,Adlai Nortye Ltd ,Company Or Adlai Nortye ,University Of Southern California ,Early Clinical Development ,Cstone Pharmaceuticals ,Archie Tse As Head Of Research Development ,Archie Tse ,Molecular Biology ,Chief Scientific Officer ,Senior Vice President ,Securities Litigation Reform Act ,Markets ,